SCHEMBL6294565

SCHEMBL6294565

Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)C[C@@H]1F

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 9/20 0.64
ADORA2A P29274 4/20 0.64
ADORA1 P30542 3/20 0.64
PDE2A O00408 3/20 0.64
PDE4D Q08499 2/20 0.64
PDE3A Q14432 2/20 0.64
ADRA1A P35348 1/20 0.64
NT5E P21589 3/20 0.62
PNP P00491 1/20 0.59
LMNA P02545 1/20 0.59
TP53 P04637 1/20 0.59
HTT P42858 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
RXFP1 Q9HBX9 1/20 0.59
CD99 P14209 1/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA4 P22748 1/20 0.49
CA9 Q16790 1/20 0.49
ADORA2B P29275 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10060179 1.00 ADORA3 (0.64) ADORA3ADORA2AADORA1PDE2APDE4D
SCHEMBL13770329 0.90 NT5E (0.61) ADORA3ADORA2AADORA1PDE2APDE4D
SCHEMBL20347280 0.89 NT5E (0.60) ADORA3ADORA2AADORA1PDE2APDE4D
SCHEMBL8620311 0.89 AHCY (0.54) ADORA3ADORA2AADORA1PDE2APDE4D
SCHEMBL13873163 0.89 AHCY (0.54) ADORA3ADORA2AADORA1PDE2APDE4D
SCHEMBL13713932 0.89 AHCY (0.54) ADORA3ADORA2AADORA1PDE2APDE4D
SCHEMBL8620317 0.89 AHCY (0.54) ADORA3ADORA2AADORA1PDE2APDE4D
SCHEMBL13890093 0.89 AHCY (0.54) ADORA3ADORA2AADORA1PDE2APDE4D
SCHEMBL3436979 0.88 PDE4D (0.66) ADORA3ADORA2AADORA1PDE2APDE4D
SCHEMBL19959557 0.88 PDE4D (0.66) ADORA3ADORA2AADORA1PDE2APDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0314011-A2 Purine derivatives F. HOFFMANN-LA ROCHE AG (CH) 1989-05-03 EP claimed
JP-1149797-A None JP disclosed
EP-3947408-B1 SALT OF TRIPHOSPHATE PHOSPHORAMIDATES OF NUCLEOTIDES AS ANTICANCER COMPOUNDS NuCana plc (GB) 2023-06-07 EP disclosed
WO-2020201751-A1 SALT OF TRIPHOSPHATE PHOSPHORAMIDATES OF NUCLEOTIDES AS ANTICANCER COMPOUNDS NuCana plc (GB) 2020-10-08 WO disclosed
WO-2018119284-A1 ECTONUCLEOTIDASE INHIBITORS AND METHODS OF USE THEREOF CALITHERA BIOSCIENCES, INC. (US) 2018-06-28 WO disclosed
WO-2018049145-A1 ECTONUCLEOTIDASE INHIBITORS AND METHODS OF USE THEREOF CALITHERA BIOSCIENCES, INC. (US) 2018-03-15 WO disclosed
WO-2017133517-A1 PHOSPHAMIDE DERIVATIVE, METHOD FOR MANUFACTURING THE SAME, AND USES THEREOF 四川海思科制药有限公司 2017-08-10 WO disclosed
US-6884880-B2 Process for the preparation of 9-β-anomeric nucleoside analogs ASH STEVENS, INC. (US) 2005-04-26 US disclosed
JP-H01149797-A PURINE DERIVATIVE F HOFFMANN LA ROCHE AG 1989-06-12 JP disclosed
EP-0314011-A2 Purine derivatives F. HOFFMANN-LA ROCHE AG (CH) 1989-05-03 EP disclosed